Expedia’s (NASDAQ:EXPE) B2B Revenue declined from around $2.6 billion in 2019 to about $1 billion in 2020. We expect the metric to rise to around $1.8 billion in 2021 and to about $1.95 billion in 2022.
Sales dropped sharply in 2020 due to the Covid-19 pandemic and the associated travel restrictions. However, with the economy reopening, we expect sales to rise over 2021 and 2022.
We think the projected recovery is fully priced into Expedia stock. We value EXPE at about $166 per share, roughly in line with the current market price.